Results 81 to 90 of about 5,917,232 (403)

Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Introduction: Obesity has always been thought to be a risk factor for diabetes; however, some studies in India have reported that even lean people are prone to diabetes.
Prateek Chaudhary   +2 more
doaj   +1 more source

Dyslipidemia in type 2 diabetes mellitus [PDF]

open access: yesArhiv za farmaciju, 2019
Type 2 diabetes mellitus is a chronic high-prevalence metabolic disease, which is characterized by hyperglycaemia, but also with lipid and protein metabolism disorders.
Stefanović Aleksandra   +5 more
doaj   +1 more source

Automatically Explaining Machine Learning Prediction Results: A Demonstration on Type 2 Diabetes Risk Prediction [PDF]

open access: yesGang Luo. Automatically Explaining Machine Learning Prediction Results: A Demonstration on Type 2 Diabetes Risk Prediction. Health Information Science and Systems, Vol. 4, No. 2, Mar. 2016, 2018
Background: Predictive modeling is a key component of solutions to many healthcare problems. Among all predictive modeling approaches, machine learning methods often achieve the highest prediction accuracy, but suffer from a long-standing open problem precluding their widespread use in healthcare.
arxiv   +1 more source

The importance of diet and exercise in preventing type 2 diabetes [PDF]

open access: yes, 2014
Diabetes is reaching epidemic proportions globally with estimates of 374 million people worldwide (WHO 2014 ) and impacts on the people with the condition, their families and on health service resources.
McDowell, Joan
core  

Taurine promotes glucagon‐like peptide‐1 secretion in enteroendocrine L cells

open access: yesFEBS Letters, EarlyView.
Taurine, a sulfur‐containing amino acid, is likely taken up by enteroendocrine L cells via the taurine transporter. This process increases the levels of cytosolic ATP. The increase in intracellular Ca2+ concentrations and glucagon‐like peptide‐1 secretion through membrane depolarization is caused by the closure of ATP‐sensitive potassium channels ...
Yuri Osuga   +6 more
wiley   +1 more source

The impact of type 2 diabetes and Microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial Disease (SMART) study [PDF]

open access: yes, 2008
Aims Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically ...
Algra, A.   +3 more
core   +3 more sources

Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. [PDF]

open access: yes, 2021
Aims: The Italian Society of Diabetology and the Italian Association of Clinical Diabetologists are developing new guidelines for drug treatment of type 2 diabetes.
Candido R   +5 more
core   +1 more source

Glucose control and vascular complications in veterans with type 2 diabetes.

open access: yesNew England Journal of Medicine, 2009
BACKGROUND The effects of intensive glucose control on cardiovascular events in patients with long-standing type 2 diabetes mellitus remain uncertain.
W. Duckworth   +15 more
semanticscholar   +1 more source

Deconstructing Type 2 Diabetes [PDF]

open access: yesCell, 1999
There is a natural temptation to extrapolate insights from these animal models to explain the pathophysiology of human diabetes. In some cases, the animal model closely resembles the human disease, as is the case with glucokinase knockout mice and MODY2.
openaire   +3 more sources

Exercise and type 2 diabetes [PDF]

open access: yes, 2021
Proefschrift dat onder andere een tweejarig interventie-onderzoek beschrijft naar het effect van een bewegingsprogramma bij personen met type 2 diabetes.
openaire   +1 more source

Home - About - Disclaimer - Privacy